Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


3 Am J Med
1 Ann Intern Med
1 Arch Virol
3 Biochem Biophys Res Commun
2 Biochemistry (Mosc)
3 BMC Pediatr
9 Cell
4 Epidemiol Infect
11 J Clin Microbiol
1 J Gen Virol
2 J Virol
7 Lancet
10 N Engl J Med
1 PLoS Biol
2 PLoS Comput Biol
1 PLoS Med
41 PLoS One
6 Proc Natl Acad Sci U S A
5 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. WEISSMANN L, Barbosa AN, Scarpellini B, Diament D, et al
    Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19.
    Am J Med. 2021;134:e341-e342.

  2. OLMOS RD, Roque FL
    Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous.
    Am J Med. 2021;134:e345.

  3. RESNIKOFF PM, Shi R, Spierling Bagsic SR, Kimura BJ, et al
    The Novel Concept of Patient Self-Imaging: Success in COVID-19 and Cardiopulmonary Disorders.
    Am J Med. 2021;134:e360-e361.

    Ann Intern Med

  4. BARON RJ, Khullar D
    Building Trust to Promote a More Equitable Health Care System.
    Ann Intern Med. 2021;174:548-549.

    Arch Virol

  5. SOKOLOVA AS, Yarovaya OI, Baranova DV, Galochkina AV, et al
    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus.
    Arch Virol. 2021 May 13. pii: 10.1007/s00705-021-05102.
    PubMed         Abstract available

    Biochem Biophys Res Commun

    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;538:97-103.
    PubMed         Abstract available

  7. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    PubMed         Abstract available

  8. Editorial.
    Biochem Biophys Res Commun. 2021;538:1.

    Biochemistry (Mosc)

  9. SHILOVSKIY IP, Yumashev KV, Nikolsky AA, Vishnyakova LI, et al
    Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology.
    Biochemistry (Mosc). 2021;86:290-306.
    PubMed         Abstract available

    COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms.
    Biochemistry (Mosc). 2021;86:389-396.
    PubMed         Abstract available

    BMC Pediatr

  11. ZHANG Y, Huang Y, Ai T, Luo J, et al
    Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China.
    BMC Pediatr. 2021;21:202.
    PubMed         Abstract available

  12. ZHU Y, Li W, Yang B, Qian R, et al
    Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak.
    BMC Pediatr. 2021;21:195.
    PubMed         Abstract available

  13. XU R, Fathima P, Strunk T, de Klerk N, et al
    RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study.
    BMC Pediatr. 2020;20:490.
    PubMed         Abstract available


  14. GILL D, Baker EH, Hitchings AW
    We need clinical guidelines fit for a pandemic.
    BMJ. 2021;373:n1093.

  15. MUGHAL F, Hossain MZ, Brady A, Samuel J, et al
    Mental health support through primary care during and after covid-19.
    BMJ. 2021;373:n1064.

  16. MOYLE J
    Pulse oximetry gives artificially high readings in presence of carboxyhaemoglobin.
    BMJ. 2021;373:n1103.

    Remote management of covid-19: we could do more, more widely.
    BMJ. 2021;373:n1095.


  18. ZHOU D, Dejnirattisai W, Supasa P, Liu C, et al
    Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
    Cell. 2021;184:2348-2361.
    PubMed         Abstract available

  19. LI Q, Nie J, Wu J, Zhang L, et al
    SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
    Cell. 2021 Feb 23. pii: S0092-8674(21)00231-2. doi: 10.1016/j.cell.2021.
    PubMed         Abstract available

  20. FLYNN RA, Belk JA, Qi Y, Yasumoto Y, et al
    Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
    Cell. 2021;184:2394-2411.
    PubMed         Abstract available

  21. GARCIA-BELTRAN WF, Lam EC, St Denis K, Nitido AD, et al
    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
    Cell. 2021;184:2372-2383.
    PubMed         Abstract available

  22. MCCALLUM M, De Marco A, Lempp FA, Tortorici MA, et al
    N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
    Cell. 2021;184:2332-2347.
    PubMed         Abstract available

  23. FABIUS JM, Krogan NJ
    Creating collaboration by breaking down scientific barriers.
    Cell. 2021;184:2271-2275.
    PubMed         Abstract available

  24. SURYADEVARA N, Shrihari S, Gilchuk P, VanBlargan LA, et al
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
    Cell. 2021;184:2316-2331.
    PubMed         Abstract available

  25. HOFFMANN M, Arora P, Gross R, Seidel A, et al
    SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Cell. 2021;184:2384-2393.
    PubMed         Abstract available

  26. BOEHM JS
    The power of parent scientists.
    Cell. 2021;184:2263-2270.
    PubMed         Abstract available

    Epidemiol Infect

  27. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    PubMed         Abstract available

  28. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    PubMed         Abstract available

  29. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    PubMed         Abstract available

  30. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    PubMed         Abstract available

    J Clin Microbiol

  31. LOCHER K, Velapatino B, Caza M, Li L, et al
    Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  32. LI D, Li J
    Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  33. LEE RA, Herigon JC, Benedetti A, Pollock NR, et al
    Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  34. HIRSCHHORN JW, Kegl A, Dickerson T, Glen WB Jr, et al
    Verification and Validation of SARS-CoV-2 Assay Performance on the Abbott m2000 and Alinity m Systems.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  35. HARRITSHOJ LH, Gybel-Brask M, Afzal S, Kamstrup PR, et al
    Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  36. RICHARD-GREENBLATT M, Comar CE, Flevaud L, Berti M, et al
    Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  37. SEMMLER G, Traugott MT, Graninger M, Hoepler W, et al
    Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  38. POLLOCK NR, Jacobs JR, Tran K, Cranston AE, et al
    Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  39. LI T, Chung HK, Pireku PK, Beitzel BF, et al
    Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation Sequencing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  40. GRIESEMER SB, Van Slyke G, Ehrbar D, Strle K, et al
    Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  41. ZOWAWI HM, Alenazi TH, AlOmaim WS, Wazzan A, et al
    Portable RT-PCR System: a Rapid and Scalable Diagnostic Tool for COVID-19 Testing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

    J Gen Virol

  42. GOLDEN JW, Zeng X, Cline CR, Garrison AR, et al
    Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Virol

  43. BAKRE A, Jones L, Murray J, Reneer ZB, et al
    Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
    J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
    PubMed         Abstract available

  44. NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
    Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
    J Virol. 2021;95.
    PubMed         Abstract available


  45. NUZZO JB, Bell JA, Cameron EE
    Suboptimal US Response to COVID-19 Despite Robust Capabilities and Resources.
    JAMA. 2020 Sep 16. pii: 2770891. doi: 10.1001/jama.2020.17395.

  46. PATEL MM, Thornburg NJ, Stubblefield WB, Talbot HK, et al
    Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.
    JAMA. 2020 Sep 17. pii: 2770928. doi: 10.1001/jama.2020.18796.

  47. OCHALEK TA, Cumpston KL, Wills BK, Gal TS, et al
    Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic.
    JAMA. 2020 Sep 18. pii: 2770986. doi: 10.1001/jama.2020.17477.

  48. WAINWRIGHT JJ, Mikre M, Whitley P, Dawson E, et al
    Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak.
    JAMA. 2020 Sep 18. pii: 2770987. doi: 10.1001/jama.2020.17694.

  49. ABBOTT J, Johnson D, Wynia M
    Ensuring Adequate Palliative and Hospice Care During COVID-19 Surges.
    JAMA. 2020 Sep 21. pii: 2771025. doi: 10.1001/jama.2020.16843.

  50. TISCH CF
    Camping Alone-Recovering From COVID-19.
    JAMA. 2020 Sep 21. pii: 2771024. doi: 10.1001/jama.2020.19304.

  51. RUBIN R
    As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts.
    JAMA. 2020 Sep 23. pii: 2771111. doi: 10.1001/jama.2020.17709.

  52. MICHAELS D, Wagner GR
    Occupational Safety and Health Administration (OSHA) and Worker Safety During the COVID-19 Pandemic.
    JAMA. 2020 Sep 16. pii: 2770890. doi: 10.1001/jama.2020.16343.

  53. PERSAD G, Peek ME, Emanuel EJ
    Fairly Prioritizing Groups for Access to COVID-19 Vaccines.
    JAMA. 2020 Sep 10. pii: 2770684. doi: 10.1001/jama.2020.18513.

  54. MCCOY MS, Libert T, Buckler D, Grande DT, et al
    Prevalence of Third-Party Tracking on COVID-19-Related Web Pages.
    JAMA. 2020 Sep 8. pii: 2770565. doi: 10.1001/jama.2020.16178.

  55. HEINTZMAN J, O'Malley J, Marino M, Todd JV, et al
    SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic.
    JAMA. 2020 Aug 31. pii: 2770242. doi: 10.1001/jama.2020.15891.

  56. WU Z, Wang Q, Zhao J, Yang P, et al
    Time Course of a Second Outbreak of COVID-19 in Beijing, China, June-July 2020.
    JAMA. 2020 Aug 24. pii: 2769930. doi: 10.1001/jama.2020.15894.

  57. STAUFFER WM, Alpern JD, Walker PF
    COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.
    JAMA. 2020 Jul 30. pii: 2769100. doi: 10.1001/jama.2020.13170.

  58. VAN DER MADE CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, et al
    Presence of Genetic Variants Among Young Men With Severe COVID-19.
    JAMA. 2020 Jul 24. pii: 2768926. doi: 10.1001/jama.2020.13719.
    PubMed         Abstract available

  59. ABBASI J
    Social Isolation-the Other COVID-19 Threat in Nursing Homes.
    JAMA. 2020 Jul 16. pii: 2768640. doi: 10.1001/jama.2020.13484.

  60. WANG X, Ferro EG, Zhou G, Hashimoto D, et al
    Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers.
    JAMA. 2020 Jul 14. pii: 2768533. doi: 10.1001/jama.2020.12897.

  61. AHLBERG M, Neovius M, Saltvedt S, Soderling J, et al
    Association of SARS-CoV-2 Test Status and Pregnancy Outcomes.
    JAMA. 2020 Sep 23. pii: 2771110. doi: 10.1001/jama.2020.19124.

  62. EL MOHEB M, Naar L, Christensen MA, Kapoen C, et al
    Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19.
    JAMA. 2020 Sep 24. pii: 2771160. doi: 10.1001/jama.2020.19400.

    The 2020 Lasker Awards and the COVID-19 Pandemic.
    JAMA. 2020 Sep 25. pii: 2770711. doi: 10.1001/jama.2020.17056.

  64. GRIECO DL, Menga LS, Cesarano M, Rosa T, et al
    Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
    JAMA. 2021 Mar 25. pii: 2778088. doi: 10.1001/jama.2021.4682.
    PubMed         Abstract available

  65. MUNSHI L, Hall JB
    Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet?
    JAMA. 2021 Mar 25. pii: 2778089. doi: 10.1001/jama.2021.4975.

  66. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.

  67. MANABE YC, Sharfstein JS, Armstrong K
    The Need for More and Better Testing for COVID-19.
    JAMA. 2020 Nov 13. pii: 2773129. doi: 10.1001/jama.2020.21694.

  68. RICHTERMAN A, Meyerowitz EA, Cevik M
    Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health.
    JAMA. 2020 Nov 13. pii: 2773128. doi: 10.1001/jama.2020.21399.

  69. RUBIN R
    First It Was Masks; Now Some Refuse Testing for SARS-CoV-2.
    JAMA. 2020 Nov 6. pii: 2772860. doi: 10.1001/jama.2020.22003.

  70. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.

  71. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.

  72. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.

  73. WALKE HT, Honein MA, Redfield RR
    Preventing and Responding to COVID-19 on College Campuses.
    JAMA. 2020 Sep 29. pii: 2771319. doi: 10.1001/jama.2020.20027.

  74. FREANEY PM, Shah SJ, Khan SS
    COVID-19 and Heart Failure With Preserved Ejection Fraction.
    JAMA. 2020 Sep 30. pii: 2771385. doi: 10.1001/jama.2020.17445.

  75. POMBAL R, Hosegood I, Powell D
    Risk of COVID-19 During Air Travel.
    JAMA. 2020 Oct 1. pii: 2771435. doi: 10.1001/jama.2020.19108.

  76. DEL RIO C, Collins LF, Malani P
    Long-term Health Consequences of COVID-19.
    JAMA. 2020 Oct 5. pii: 2771581. doi: 10.1001/jama.2020.19719.

  77. MEREDITH JW, High KP, Freischlag JA
    Preserving Elective Surgeries in the COVID-19 Pandemic and the Future.
    JAMA. 2020 Oct 5. pii: 2771580. doi: 10.1001/jama.2020.19594.

  78. ABBASI J
    Large Meta-analysis Digs Into Obesity's COVID-19 Risks.
    JAMA. 2020 Oct 15. pii: 2772071. doi: 10.1001/jama.2020.18637.

  79. SEYMOUR CW, McCreary EK, Stegenga J
    Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.
    JAMA. 2020 Oct 15. pii: 2772072. doi: 10.1001/jama.2020.20271.


    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.

  81. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.

  82. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.

  83. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    PubMed         Abstract available

  84. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.

  85. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.

  86. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.

    N Engl J Med

  87. LIU Y, Liu J, Xia H, Zhang X, et al
    Neutralizing Activity of BNT162b2-Elicited Serum.
    N Engl J Med. 2021;384:1466-1468.

  88. GORALNICK E, Kaufmann C, Gawande AA
    Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.

  89. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.

  90. BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
    BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.

  91. KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
    SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.

  92. HERZOG N, Giacardi C, Danguy des Deserts M
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.

    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.

  94. PATEL J, Janapala RN, Pourmand A
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.

  95. CANELLI R, Shrestha GS, Ortega R
    Emergency Intubation in Covid-19. Reply.
    N Engl J Med. 2021;384.

  96. RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
    Audio Interview: India's Covid-19 Crisis.
    N Engl J Med. 2021;384:e84.

    PLoS Biol

  97. GALLAGHER T, McCray PB Jr
    The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
    PLoS Biol. 2021;19:e3001217.
    PubMed         Abstract available

    PLoS Comput Biol

  98. SHARKER Y, Kenah E
    Estimating and interpreting secondary attack risk: Binomial considered biased.
    PLoS Comput Biol. 2021;17:e1008601.
    PubMed         Abstract available

  99. MOORE S, Hill EM, Dyson L, Tildesley MJ, et al
    Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.
    PLoS Comput Biol. 2021;17:e1008849.
    PubMed         Abstract available

    PLoS Med

  100. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    PubMed         Abstract available

    PLoS One

  101. TADDESE AA, Azene ZN, Merid MW, Muluneh AG, et al
    Knowledge and attitude of the communities towards COVID-19 and associated factors among Gondar City residents, northwest Ethiopia: A community based cross-sectional study.
    PLoS One. 2021;16:e0248821.
    PubMed         Abstract available

  102. BARRIA-SANDOVAL C, Ferreira G, Benz-Parra K, Lopez-Flores P, et al
    Prediction of confirmed cases of and deaths caused by COVID-19 in Chile through time series techniques: A comparative study.
    PLoS One. 2021;16:e0245414.
    PubMed         Abstract available

  103. ARNOLD DT, Donald C, Lyon M, Hamilton FW, et al
    Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.
    PLoS One. 2021;16:e0249607.
    PubMed         Abstract available

  104. BAYE AM, Ababu A, Bayisa R, Abdella M, et al
    Perspectives of compounding pharmacists on alcohol-based hand sanitizer production and utilization for COVID-19 prevention in Addis Ababa, Ethiopia: A descriptive phenomenology study.
    PLoS One. 2021;16:e0250020.
    PubMed         Abstract available

  105. SALAZAR MR, Gonzalez SE, Regairaz L, Ferrando NS, et al
    Risk factors for COVID-19 mortality: The effect of convalescent plasma administration.
    PLoS One. 2021;16:e0250386.
    PubMed         Abstract available

  106. D'HUMIERES C, Patrier J, Lortat-Jacob B, Tran-Dinh A, et al
    Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
    PLoS One. 2021;16:e0250728.
    PubMed         Abstract available

  107. MADRU C, Tekpinar AD, Rosario S, Czernecki D, et al
    Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.
    PLoS One. 2021;16:e0250610.
    PubMed         Abstract available

  108. MERZA MY, Hwaiz RA, Hamad BK, Mohammad KA, et al
    Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.
    PLoS One. 2021;16:e0250330.
    PubMed         Abstract available

  109. HUFSTEDLER H, Matthay EC, Rahman S, de Jong VMT, et al
    Current trends in the application of causal inference methods to pooled longitudinal observational infectious disease studies-A protocol for a methodological systematic review.
    PLoS One. 2021;16:e0250778.
    PubMed         Abstract available

  110. AL-MUSHARAF S, Aljuraiban G, Bogis R, Alnafisah R, et al
    Lifestyle changes associated with COVID-19 quarantine among young Saudi women: A prospective study.
    PLoS One. 2021;16:e0250625.
    PubMed         Abstract available

  111. SALTO-ALEJANDRE S, Jimenez-Jorge S, Sabe N, Ramos-Martinez A, et al
    Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.
    PLoS One. 2021;16:e0250796.
    PubMed         Abstract available

  112. TOMBULOGLU H, Sabit H, Al-Suhaimi E, Al Jindan R, et al
    Development of multiplex real-time RT-PCR assay for the detection of SARS-CoV-2.
    PLoS One. 2021;16:e0250942.
    PubMed         Abstract available

  113. UR RAHMAN I, Jian D, Junrong L, Shafi M, et al
    Socio-economic status, resilience, and vulnerability of households under COVID-19: Case of village-level data in Sichuan province.
    PLoS One. 2021;16:e0249270.
    PubMed         Abstract available

  114. MOLLA KA, Abegaz SB
    Community knowledge, attitude and practices to SARS-CoV-2 disease 2019 (COVID-19): A cross-sectional study in Woldia town, Northeast Ethiopia.
    PLoS One. 2021;16:e0250465.
    PubMed         Abstract available

  115. FRIDMAN A, Gershon R, Gneezy A
    COVID-19 and vaccine hesitancy: A longitudinal study.
    PLoS One. 2021;16:e0250123.
    PubMed         Abstract available

  116. RAMATILLAH DL, Isnaini S
    Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.
    PLoS One. 2021;16:e0250147.
    PubMed         Abstract available

  117. ISMAIL II, Abdelkarim A, Al-Hashel JY
    Physicians' attitude towards webinars and online education amid COVID-19 pandemic: When less is more.
    PLoS One. 2021;16:e0250241.
    PubMed         Abstract available

  118. AFULANI PA, Gyamerah AO, Nutor JJ, Laar A, et al
    Inadequate preparedness for response to COVID-19 is associated with stress and burnout among healthcare workers in Ghana.
    PLoS One. 2021;16:e0250294.
    PubMed         Abstract available

  119. KOLLAMPARAMBIL U, Oyenubi A
    Behavioural response to the Covid-19 pandemic in South Africa.
    PLoS One. 2021;16:e0250269.
    PubMed         Abstract available

  120. NWAGBARA UI, Osual EC, Chireshe R, Bolarinwa OA, et al
    Knowledge, attitude, perception, and preventative practices towards COVID-19 in sub-Saharan Africa: A scoping review.
    PLoS One. 2021;16:e0249853.
    PubMed         Abstract available

  121. OGDEN R
    Distortions to the passage of time during England's second national lockdown: A role for depression.
    PLoS One. 2021;16:e0250412.
    PubMed         Abstract available

  122. NAJMI A, Nazari S, Safarighouzhdi F, MacIntyre CR, et al
    Facemask and social distancing, pillars of opening up economies.
    PLoS One. 2021;16:e0249677.
    PubMed         Abstract available

  123. DOGHISH AS, Elkhatib WF, Hassan EA, Elkhateeb AF, et al
    Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    PLoS One. 2021;16:e0249346.
    PubMed         Abstract available

  124. DENNING M, Goh ET, Tan B, Kanneganti A, et al
    Determinants of burnout and other aspects of psychological well-being in healthcare workers during the Covid-19 pandemic: A multinational cross-sectional study.
    PLoS One. 2021;16:e0238666.
    PubMed         Abstract available

  125. AWWAD FA, Mohamoud MA, Abonazel MR
    Estimating COVID-19 cases in Makkah region of Saudi Arabia: Space-time ARIMA modeling.
    PLoS One. 2021;16:e0250149.
    PubMed         Abstract available

  126. IBRAHIM ME, Al-Aklobi OS, Abomughaid MM, Al-Ghamdi MA, et al
    Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
    PLoS One. 2021;16:e0250955.
    PubMed         Abstract available

  127. GREEN MS, Nitzan D, Schwartz N, Niv Y, et al
    Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.
    PLoS One. 2021;16:e0250523.
    PubMed         Abstract available

  128. SHRESTHA R, Siwakoti S, Singh S, Shrestha AP, et al
    Impact of the COVID-19 pandemic on suicide and self-harm among patients presenting to the emergency department of a teaching hospital in Nepal.
    PLoS One. 2021;16:e0250706.
    PubMed         Abstract available

  129. OKDA FA, Perry SS, Webby RJ, Russell CJ, et al
    Interplay between H1N1 influenza a virus infection, extracellular and intracellular respiratory tract pH, and host responses in a mouse model.
    PLoS One. 2021;16:e0251473.
    PubMed         Abstract available

  130. HOSEN I, Pakpour AH, Sakib N, Hussain N, et al
    Knowledge and preventive behaviors regarding COVID-19 in Bangladesh: A nationwide distribution.
    PLoS One. 2021;16:e0251151.
    PubMed         Abstract available

  131. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    PubMed         Abstract available

    Mathematical model for the mitigation of the economic effects of the Covid-19 in the Democratic Republic of the Congo.
    PLoS One. 2021;16:e0250775.
    PubMed         Abstract available

  133. GUTU B, Legese G, Fikadu N, Kumela B, et al
    Assessment of preventive behavior and associated factors towards COVID-19 in Qellam Wallaga Zone, Oromia, Ethiopia: A community-based cross-sectional study.
    PLoS One. 2021;16:e0251062.
    PubMed         Abstract available

  134. ACHARYA R, Poudel D, Patel A, Schultz E, et al
    Low serum albumin and the risk of hospitalization in COVID-19 infection: A retrospective case-control study.
    PLoS One. 2021;16:e0250906.
    PubMed         Abstract available

  135. ELHADI M, Alsoufi A, Abusalama A, Alkaseek A, et al
    Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study.
    PLoS One. 2021;16:e0251085.
    PubMed         Abstract available

  136. YUAN X, Xi H, Le Y, Xu H, et al
    Online survey on healthcare skin reactions for wearing medical-grade protective equipment against COVID-19 in Hubei Province, China.
    PLoS One. 2021;16:e0250869.
    PubMed         Abstract available

  137. INKELAS M, Blair C, Furukawa D, Manuel VG, et al
    Using control charts to understand community variation in COVID-19.
    PLoS One. 2021;16:e0248500.
    PubMed         Abstract available

  138. ATNAFIE SA, Anteneh DA, Yimenu DK, Kifle ZD, et al
    Assessment of exposure risks to COVID-19 among frontline health care workers in Amhara Region, Ethiopia: A cross-sectional survey.
    PLoS One. 2021;16:e0251000.
    PubMed         Abstract available

  139. HAMMOND A, Khalid T, Thornton HV, Woodall CA, et al
    Should homes and workplaces purchase portable air filters to reduce the transmission of SARS-CoV-2 and other respiratory infections? A systematic review.
    PLoS One. 2021;16:e0251049.
    PubMed         Abstract available

  140. VARGHESE NE, Sabat I, Neumann-Bohme S, Schreyogg J, et al
    Risk communication during COVID-19: A descriptive study on familiarity with, adherence to and trust in the WHO preventive measures.
    PLoS One. 2021;16:e0250872.
    PubMed         Abstract available

  141. LEITH DJ, Farrell S
    Measurement-based evaluation of Google/Apple Exposure Notification API for proximity detection in a commuter bus.
    PLoS One. 2021;16:e0250826.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  142. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  143. GENG X, Katul GG, Gerges F, Bou-Zeid E, et al
    A kernel-modulated SIR model for Covid-19 contagious spread from county to continent.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  144. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  145. KANG S, Tanaka T, Inoue H, Ono C, et al
    Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.
    Proc Natl Acad Sci U S A. 2021;118.

  146. BAIR E, Stillinger T, Rittger K, Skiles M, et al
    COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  147. CHENG L, Zhu Z, Wang C, Wang P, et al
    COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
    Proc Natl Acad Sci U S A. 2021;118.


  148. LEUNG VKY, Fox A, Carolan LA, Aban M, et al
    Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
    PubMed         Abstract available

  149. POWELL H, Liu H, Pekosz A
    Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
    PubMed         Abstract available

  150. CORREIA R, Meneses L, Richheimer C, Alves PM, et al
    Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
    PubMed         Abstract available

  151. KIM S, Williams TC, Viboud C, Campbell H, et al
    RSV genomic diversity and the development of a globally effective RSV intervention.
    Vaccine. 2021;39:2811-2820.
    PubMed         Abstract available

  152. WANG C, Han B, Zhao T, Liu H, et al
    Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.